MSB Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD - 1st Feb 2023, 9:30am

annb0t

annb0t

Top 20
MSB Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
Price Sensitive: Y
Date: 1st Feb 2023, 9:30am

>>> Read announcement: Google: MSB Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
MSB Ann: Mesoblast Type A Meeting with FDA - 21st Sep 2023, 10:09am
Replies
0
Views
113
annb0t
annb0t
annb0t
MSB Ann: Mesoblast 2023 Full Year Financial Results Webcast - 29th Aug 2023, 5:53pm
Replies
0
Views
113
annb0t
annb0t
annb0t
MSB Ann: Mesoblast Director Appointed to Strategic Advisory Role - 5th Jun 2023, 9:41am
Replies
0
Views
147
annb0t
annb0t
annb0t
MSB Ann: Mesoblast Third Quarter Financial Results Webcast - 24th May 2023, 6:02pm
Replies
0
Views
143
annb0t
annb0t
annb0t
MSB Ann: Mesoblast Completes Private Placement - 26th Apr 2023, 9:54am
Replies
0
Views
130
annb0t
annb0t
Top Bottom